190 related articles for article (PubMed ID: 33325042)
1. The mitochondria-targeted hydrogen sulfide donor AP39 improves health and mitochondrial function in a C. elegans primary mitochondrial disease model.
Fox BC; Slade L; Torregrossa R; Pacitti D; Szabo C; Etheridge T; Whiteman M
J Inherit Metab Dis; 2021 Mar; 44(2):367-375. PubMed ID: 33325042
[TBL] [Abstract][Full Text] [Related]
2. AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons.
Zhao FL; Fang F; Qiao PF; Yan N; Gao D; Yan Y
Oxid Med Cell Longev; 2016; 2016():8360738. PubMed ID: 27057285
[TBL] [Abstract][Full Text] [Related]
3. The novel mitochondria-targeted hydrogen sulfide (H
Gerő D; Torregrossa R; Perry A; Waters A; Le-Trionnaire S; Whatmore JL; Wood M; Whiteman M
Pharmacol Res; 2016 Nov; 113(Pt A):186-198. PubMed ID: 27565382
[TBL] [Abstract][Full Text] [Related]
4. AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo.
Ahmad A; Olah G; Szczesny B; Wood ME; Whiteman M; Szabo C
Shock; 2016 Jan; 45(1):88-97. PubMed ID: 26513708
[TBL] [Abstract][Full Text] [Related]
5. AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.
Szczesny B; Módis K; Yanagi K; Coletta C; Le Trionnaire S; Perry A; Wood ME; Whiteman M; Szabo C
Nitric Oxide; 2014 Sep; 41():120-30. PubMed ID: 24755204
[TBL] [Abstract][Full Text] [Related]
6. The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H
Pomierny B; Krzyżanowska W; Jurczyk J; Skórkowska A; Strach B; Szafarz M; Przejczowska-Pomierny K; Torregrossa R; Whiteman M; Marcinkowska M; Pera J; Budziszewska B
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360581
[TBL] [Abstract][Full Text] [Related]
7. AP39 ameliorates high fat diet-induced liver injury in young rats via alleviation of oxidative stress and mitochondrial impairment.
Yu Y; Ye SM; Liu DY; Yang LQ
Exp Anim; 2021 Nov; 70(4):553-562. PubMed ID: 34305077
[TBL] [Abstract][Full Text] [Related]
8. AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts: Relevance for Preeclampsia Pathogenesis.
Covarrubias AE; Lecarpentier E; Lo A; Salahuddin S; Gray KJ; Karumanchi SA; Zsengellér ZK
Am J Pathol; 2019 Jan; 189(1):104-114. PubMed ID: 30315766
[TBL] [Abstract][Full Text] [Related]
9. Both the H
Ahmad A; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):348-355. PubMed ID: 27639598
[TBL] [Abstract][Full Text] [Related]
10. AP39, a mitochondria-targeting hydrogen sulfide (H
Karwi QG; Bornbaum J; Boengler K; Torregrossa R; Whiteman M; Wood ME; Schulz R; Baxter GF
Br J Pharmacol; 2017 Feb; 174(4):287-301. PubMed ID: 27930802
[TBL] [Abstract][Full Text] [Related]
11. Supplementing preservation solution with mitochondria-targeted H
Zhu C; Su Y; Juriasingani S; Zheng H; Veramkovich V; Jiang J; Sener A; Whiteman M; Lacefield J; Nagpal D; Alotaibi F; Liu K; Zheng X
Am J Transplant; 2019 Nov; 19(11):3139-3148. PubMed ID: 31338943
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide supplementation as a potential treatment for primary mitochondrial diseases.
Slade L; Deane CS; Szewczyk NJ; Etheridge T; Whiteman M
Pharmacol Res; 2024 May; 203():107180. PubMed ID: 38599468
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice.
Ikeda K; Marutani E; Hirai S; Wood ME; Whiteman M; Ichinose F
Nitric Oxide; 2015 Sep; 49():90-6. PubMed ID: 25960429
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria-Targeted Hydrogen Sulfide Delivery Molecules Protect Against UVA-Induced Photoaging in Human Dermal Fibroblasts, and in Mouse Skin
Lohakul J; Jeayeng S; Chaiprasongsuk A; Torregrossa R; Wood ME; Saelim M; Thangboonjit W; Whiteman M; Panich U
Antioxid Redox Signal; 2022 Jun; 36(16-18):1268-1288. PubMed ID: 34235951
[No Abstract] [Full Text] [Related]
16. Mitochondria-targeted hydrogen sulfide donors versus acute oxidative gastric mucosal injury.
Magierowska K; Korbut E; Wójcik-Grzybek D; Bakalarz D; Sliwowski Z; Cieszkowski J; Szetela M; Torregrossa R; Whiteman M; Magierowski M
J Control Release; 2022 Aug; 348():321-334. PubMed ID: 35654168
[TBL] [Abstract][Full Text] [Related]
17. The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease.
Ng LF; Gruber J; Cheah IK; Goo CK; Cheong WF; Shui G; Sit KP; Wenk MR; Halliwell B
Free Radic Biol Med; 2014 Jun; 71():390-401. PubMed ID: 24637264
[TBL] [Abstract][Full Text] [Related]
18. The pursuit of precision mitochondrial medicine: Harnessing preclinical cellular and animal models to optimize mitochondrial disease therapeutic discovery.
Falk MJ
J Inherit Metab Dis; 2021 Mar; 44(2):312-324. PubMed ID: 33006762
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial sulfide promotes life span and health span through distinct mechanisms in developing versus adult treated
Vintila AR; Slade L; Cooke M; Willis CRG; Torregrossa R; Rahman M; Anupom T; Vanapalli SA; Gaffney CJ; Gharahdaghi N; Szabo C; Szewczyk NJ; Whiteman M; Etheridge T
Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2216141120. PubMed ID: 37523525
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-targeted hydrogen sulfide attenuates endothelial senescence by selective induction of splicing factors
Latorre E; Torregrossa R; Wood ME; Whiteman M; Harries LW
Aging (Albany NY); 2018 Jul; 10(7):1666-1681. PubMed ID: 30026406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
